Lumos Pharma, Inc. (LUMO) Financials

LUMO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 40.6 million 13.3 million
2023-09-30 47.8 million 12.3 million
2023-06-30 56.4 million 12.7 million
2023-03-31 63.7 million 11.2 million

LUMO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -7.4 million 524000
2023-09-30 -1.4 million 559000
2023-06-30 -10.6 million 653000
2023-03-31 -11.7 million 586000

LUMO Net Income

No data available :(

LUMO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 36.1 million - 585000
2023-09-30 42.7 million - 269000
2023-06-30 50.9 million - 346000
2023-03-31 58.0 million - 421000

LUMO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 8.1 million
2023-09-30 8.0 million
2023-06-30 8.2 million
2023-03-31 8.2 million

LUMO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 6.7 million 4.2 million 18000
2023-09-30 6.4 million 5.0 million 3.9 million -
2023-06-30 3.9 million 6.0 million 4.1 million -
2023-03-31 2.5 million 4.4 million 4.4 million -

LUMO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 826000 18000
2023-09-30 7000 8000
2023-06-30 527000 9000
2023-03-31 691000 9000

LUMO

Price: $2.81

52 week price:
2.41
4.55

Earnings Per Share: -4.18 USD

P/E Ratio: -0.76

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 22134

Market Capitalization: 21.4 million

Links: